Certain packages of TUMS antacid recalled, tablets may contain fibreglass and aluminum foil

Certain packages of TUMS antacid have been recalled after tablets were found to contain fibreglass fragments, aluminum foil and "other material," according to Health Canada.
Health Canada said in a recall notice Wednesday, TUMS Peppermint Regular Strength tablets, sold in package of three rolls containing 12 tablets each, have been recalled because some tablets were found to contain "fragments of fibreglass and other material, including paper and aluminum foil."
"If consumed, the fragments should pass through most people's digestive systems with no concern," the national health agency said. "However, elderly people and people who have narrow areas in their intestines because of disease or surgery may be at risk of injury."
The affected product has the expiry date of August 2027, and was distributed across the country at the end of October.
TUMS is an antacid and is used to relieve indigestion and heartburn. Health Canada is advising consumers who have used the affected product to contact their doctor should they have concerns about their health.
COVID-19 COVERAGE
CTVNews.ca Top Stories
Canadian police chiefs speak out on death of Black man beaten by U.S. officers
Canadian police chiefs condemned on Friday the death of a Black man who was savagely beaten by police during a traffic stop in the United States, saying the officers involved must be held accountable.

How to get over the 'mental hurdle' of being active in the winter
When the cold and snow have people hunkering down, these outdoor enthusiasts find motivation in braving the Canadian winter through community and sport.
Memphis police disband unit that beat Tyre Nichols
The Memphis police chief on Saturday disbanded the unit whose officers beat to death Tyre Nichols as the nation and the city struggled to come to grips with video showing police pummelling the Black motorist.
B.C. toxic drug crisis: Fewer 911 calls as deaths continue
BC Emergency Health Services saw a slight decline in 911 calls for overdose and drug toxicity last year, but some areas saw a dramatic increase, and the death rate doesn’t appear to be slowing down.
Hearing testimonies from e-cigarette users may deter students from vaping: study
According to a new study, showing university students the health risks of vaping through experts and personal testimonies can help deter them from using e-cigarettes.
Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
Health Canada says it will continue to recommend COVID-19 prevention drug, Evulsheld, despite U.S. FDA pulling back its emergency use authorization due to concerns around its efficacy against Omicron subvariant 'Kraken.'
Germany won't be a 'party to the war' amid tanks exports to Ukraine: Ambassador
The German ambassador to Canada says Germany will not become 'a party to the conflict' in Ukraine, despite it and several other countries announcing they'll answer President Volodymyr Zelenskyy's pleas for tanks, possibly increasing the risk of Russian escalation.
W5 EXCLUSIVE | Interviewing a narco hitman: my journey into Mexico's cartel heartland
W5 goes deep into the narco heartland to interview a commander with one of Mexico's most brutal cartels. W5's documentary 'Narco Avocados' airs Saturday at 7 pm on CTV.
OPINION | Selling a home? How to know if you qualify for a capital gains exemption
When selling a home, Canadians may be exempted from paying capital gains tax on a residential property -- if it's their principal residence. On CTVNews.ca, personal finance contributor Christopher Liew explains what's determined as a principal residence, and what properties are eligible for the exemption.